In this study, targeting LINK‐A with the nucleic acid drug ASO could alleviate obesity and metabolic disorders in mice and further restore adipose tissue thermogenic capacity by remodeling the local microenvironment. This evidence concerns the gene LINC01139 and obesity disorder.